GATC Schedule

GATC Event Schedule

November 11, 2025

8:00 am - 8:30 am
Registration, Breakfast and Coffee
Foyer
Grand A + B
8:30 am - 8:40am
Welcome and Opening Remarks
Eric Kelsic
Grand A + B
8:40 - 9:00am
How and Why to Cure Prion Disease
Sonia Vallabh
Grand A + B
9:00 - 9:45am
Genetic Agency Conversations
Misha Glouberman
Grand A + B
9:45 - 10:05am
Break
10:05 - 10:25am
Rare Disease Access to Gene Therapy: Update on ASGCT Role
Terence Flotte
Grand A + B
10:25 - 10:40 am
Dyno Therapeutics: Empowering Patients with Genetic Agency
Eric Kelsic
Grand A + B
10:40 - 10:50 am
Break
10:50 - 12:50 pm
Platform Sessions with Discussions
Broadening Patient Impact
Grand C
Introduction to Session
Tyson Bertmaring
Gene Therapy as a Disruptive Technology
Jim Wilson
Rethinking how we fund, build and sustain the next generation of therapies
Laura Lande-Diner
Genetic Surgery for Genetic Agency: building a procedural model for delivering ultra rare disease therapies
Winston Yan
Focal Administration of AAV Therapies for Severe Neurological Diseases
Josh Leeman
Silencing the Critics: Scaling Gene Therapy for Human and Animal Health
Dan Oliver
Solving Gene Delivery
Grand D
Dyno-bn8, safe and therapeutic gene delivery for muscle gene therapies
Adrian Veres
Circular single-stranded DNA: Building the next generation of genetic cargo
Floris Engelhardt
Shuttling precision genetic medicines into the CNS using human TfR1-binding AAV capsids
Ben Deverman
TRACER Capsid Platform for Systemic Gene Delivery to the CNS
Mathieu Nonnenmacher
Amplifying the promise of RNA medicines to empower genetic agency
Cory Sago
AI-powered drug delivery: Unlocking programmable science
Yogev Debbi
Redefining Gene Delivery Through Plant-Based Manufacturing
Daniel Gibbs
Manufacturing agency via scalable methods
Gaurav Venkataraman
Genetic Information & Intervention
Grand E
Introduction to Session
Eric Kelsic
AI-Programmable Gene Insertion: A Path to Genetic Agency for All
John Finn
Genetic medicine platforms at the AAV-RNA Interface
Aravind Asokan
Agency begins with knowing what to do
Martin Borch Jensen
Massively Multiplexed In Vivo Screening of AI-Designed Proteins Enables Programmable Tissue Targeting
Pierce Ogden
The future of genetic medicine: smarter platforms, broader access, deeper impact
Federico Mingozzi
Function-First Biologics Engineering in the Era of Genetic Agency
Emma West
Genetic agency through programmable biology tools
Jonathan Gootenberg & Omar Abudayyeh
Fireside Chat
Eric Kelsic, George Church & Kevin Davies
AI meets Genetic Agency
Commonwealth A+B
Introduction to AI for genetic agency
Sam Sinai
Accelerating the pace of scientific discovery
Daniel Burkhardt
Treating cancer like the polygenic disease that it is
Nima Alidoust
Modeling missense variants to gain insight into causal human biology
Hilary Finucane
Advancing Genetic Agency via Programmable Biologics
Pranam Chatterjee
BoltzGen: Toward Universal Binder Design
Hannes Stärk
Democratizing gene editing with AI
Hilary Eaton
Scaling generative models for functional protein design
Ava Amini
Code to Cure: Build Models, Agents, AI-XR Co-scientists to Drive Biomedical Innovation
Le Cong
Innovation and Genetic Agency in the Age of AI
Andrew Giessel
Panel Discussion: The role of AI agents in the future of discovery, development and technologies that enable genetic agency
Fay Lin, Le Cong, Andrew Giessel, Elahe Vedadi & David Levy-Booth
12:50 - 1:50pm
Buffet Lunch
Foyer
Grand A + B
1:50 - 2:10pm
AI & Genetic Agency
George Church
Grand A + B
2:10 - 2:30pm
Three Eras of Genetic Medicine: Creating the Path
Sylke Poehling
Grand A + B
2:30 - 3:40pm
Roundtable Conversations
For the detailed list of roundtable topics click here
Grand A + B
3:40 - 4:00pm
Break
4:00 - 4:30pm
Fireside Chat
Victoria Gray & Eric Kelsic
Grand A+B
4:30 - 4:50pm
The Parents’ Journey Through Drug Development: The Angelman Syndrome story of making the impossible possible
Allyson Berent
Grand A+B
4:50 - 5:20pm
Reflections and Closing
Eric Kelsic & Misha Glouberman
Grand A+B
5:20 - 7:00pm
Reception and Happy Hour
Foyer